Stryker Corporation (SYK)
- Previous Close
334.68 - Open
334.95 - Bid --
- Ask --
- Day's Range
329.21 - 335.33 - 52 Week Range
249.98 - 361.41 - Volume
1,210,549 - Avg. Volume
1,253,906 - Market Cap (intraday)
125.611B - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
37.60 - EPS (TTM)
8.77 - Earnings Date Aug 1, 2024 - Aug 5, 2024
- Forward Dividend & Yield 3.20 (0.97%)
- Ex-Dividend Date Jun 28, 2024
- 1y Target Est
379.41
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
www.stryker.comRecent News: SYK
Performance Overview: SYK
Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SYK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SYK
Valuation Measures
Market Cap
125.61B
Enterprise Value
136.07B
Trailing P/E
37.64
Forward P/E
27.78
PEG Ratio (5yr expected)
2.81
Price/Sales (ttm)
6.04
Price/Book (mrq)
6.55
Enterprise Value/Revenue
6.49
Enterprise Value/EBITDA
26.30
Financial Highlights
Profitability and Income Statement
Profit Margin
16.03%
Return on Assets (ttm)
7.23%
Return on Equity (ttm)
18.64%
Revenue (ttm)
20.96B
Net Income Avi to Common (ttm)
3.36B
Diluted EPS (ttm)
8.77
Balance Sheet and Cash Flow
Total Cash (mrq)
2.41B
Total Debt/Equity (mrq)
69.89%
Levered Free Cash Flow (ttm)
2.29B
Research Analysis: SYK
Company Insights: SYK
SYK does not have Company Insights